Cargando…
NF-κB, Mesenchymal Differentiation and Glioblastoma
Although glioblastoma (GBM) has always been recognized as a heterogeneous tumor, the advent of largescale molecular analysis has enabled robust categorization of this malignancy into several specific subgroups. Among the subtypes designated by expression profiling, mesenchymal tumors have been assoc...
Autor principal: | Yamini, Bakhtiar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162779/ https://www.ncbi.nlm.nih.gov/pubmed/30200302 http://dx.doi.org/10.3390/cells7090125 |
Ejemplares similares
-
CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma
por: Voce, David J., et al.
Publicado: (2021) -
NF-κB Signalling in Glioblastoma
por: Soubannier, Vincent, et al.
Publicado: (2017) -
An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma
por: Lyne, Seán B., et al.
Publicado: (2021) -
DNA damage-induced cytotoxicity is mediated by the cooperative interaction of phospho-NF-κB p50 and a single nucleotide in the κB-site
por: Crawley, Clayton D., et al.
Publicado: (2013) -
Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway
por: Lou, Jia-Cheng, et al.
Publicado: (2017)